Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • burns_newsome
    Junior Member
    • May 2018
    • 1

    #1

    RNA Degradation or DNA Contamination

    Hi all,

    I have been attempting to extract RNA (RNeasy Micro Kit) from mouse retinal cells collected using laser capture microscopy, but our bioanalyzer results have been quite strange recently. The first time I ran LCM-collected samples through the bioanalyzer I got decent results, collecting somewhere between 200-500 pg/ul RNA (what I would expect given the number of cells I collect) with relatively little degradation. More recently, however, I've been picking up around 2500 pg/ul (way too high - doesn't make sense) and getting very odd bioanalyzer results.

    See recent electropherograms here

    For the life of me, I can't figure out what's going on. Some have told me that it's DNA contamination and others have said that it's RNA degradation. I've run non-LCM samples through the bioanalyzer and gotten fine results (though these samples have WAY more tissue) and I've tested other people's DNAses and gotten the same result.

    Does anyone here have experience with RNA quality like this or know what is going on here?

    Thanks,
    Burns

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
39 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
45 views
0 reactions
Last Post SEQadmin2  
Working...